A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer.
Chappuis
P O
PO
Goffin
J
J
Wong
N
N
Perret
C
C
Ghadirian
P
P
Tonin
P N
PN
Foulkes
W D
WD
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000601:surgery; D017024:Chemotherapy, Adjuvant / Q000379:methods; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006801:Humans; D020360:Neoadjuvant Therapy / Q000379:methods*; D017239:Paclitaxel / Q000627:therapeutic use; D011300:Preoperative Care / Q000379:methods; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel